Abeona Therapeutics Inc. ABEO

Set alert

Price alert · ABEO

All alert types
4.25 USD -0.10 -2.30%

At close · Nov 2

4.29 +0.04 +0.94%

After hours · Nov 2, 4:00 PM ET

Bid
4.26 × 2
Ask
4.27 × 2
4.16 Day range 4.46
4.00 52-week range 7.65
YTD
-19.35%
1 year
-11.64%
Open
4.43
Prev close
4.35
Mkt cap
243.03M
Vol
1.01M
Avg vol
1.35M
EPS
-1.18
P/E
0.00
Div yield
0.00%
More statistics
Low
4.16
High
4.46
Forward P/E
-3.84
Beta
1.50
Short ratio
10.79
Inst. own
77.54%
Dividend
0.00
Ex-div date
50-d avg
6.15
200-d avg
5.64
1y target
16.75

MAX chart

Chart tools
Interval

Events in this range
  • Jun 5, 1998Split: 0.05 for 1
  • Jun 5, 2006Split: 0.2 for 1
Signals (40)
NameDateAgo
SMA: BearishSep 1, 20262 months ago
SMA: BullishMar 1, 20268 months ago
SMA: BearishSep 1, 20251 year ago
SMA: BullishJun 1, 20242 years ago
SMA: BearishMar 1, 20242 years ago
SMA: BullishDec 1, 20232 years ago
SMA: BearishSep 1, 20188 years ago
SMA: BullishSep 1, 201610 years ago
SMA: BearishDec 1, 201015 years ago
SMA: BullishSep 1, 201016 years ago
SMA: BearishMar 1, 201016 years ago
SMA: BullishJun 1, 200917 years ago
SMA: BearishSep 1, 200818 years ago
SMA: BullishMar 1, 200818 years ago
SMA: BearishDec 1, 200718 years ago
SMA: BullishSep 1, 200719 years ago
SMA: BearishMar 1, 200719 years ago
SMA: BullishDec 1, 200619 years ago
SMA: BearishSep 1, 200422 years ago
SMA: BearishJun 1, 200422 years ago

Newest 20 of 40.

Analyst view

Consensus: strong buy

Strong buy
Price target (mean) 16.75 +294.1% upside
Target (low)
9.50
Target (mean)
16.75
Target (high)
21.00
Ratings (0m) 5 5 buy · 0 hold · 0 sell
  • Strong buy1
  • Buy4
  • Hold0
  • Sell0
  • Strong sell0

Recommendation trend

  • This month 5
  • 1 month ago 5
  • 2 months ago 5

Earnings and revenue estimates

Consensus for the coming quarters and fiscal years

ABEO analyst estimates
PeriodEPS estimateLow – highYear agoEPS growthRevenue estimateRevenue growthAnalysts
Current quarter-0.34-0.34 – -0.34-0.4802+29.2%83.33K0.0%2
Next quarter-0.385-0.39 – -0.38-0.5227+26.3%125.00K0.0%2
Current year-1.56-1.57 – -1.55-1.94+19.5%83.33K-97.6%2
Next year-1.13-1.20 – -1.05-1.56+27.9%18.81M+22478.5%2

Upgrades and downgrades

The latest rating changes

ABEO analyst upgrades and downgrades
DateFirmActionFromTo
Nov 25, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 31, 2024HC Wainwright & Co.ReiteratedBuyBuy
Oct 29, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Aug 14, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 12, 2024HC Wainwright & Co.ReiteratedBuyBuy
Jul 3, 2024HC Wainwright & Co.Initiated—Buy
May 30, 2024StifelInitiated—Buy
May 16, 2024Cantor FitzgeraldMaintainedOverweightOverweight
Apr 23, 2024Cantor FitzgeraldReiteratedOverweightOverweight
Aug 24, 2023Cantor FitzgeraldReiteratedOverweightOverweight
Jul 13, 2023Cantor FitzgeraldReiteratedOverweightOverweight
May 24, 2023Alliance Global PartnersReiterated—Buy
Nov 14, 2022SVB LeerinkMaintained—Market Perform
Nov 8, 2022Cantor FitzgeraldMaintained—Overweight
Aug 11, 2022SVB LeerinkMaintained—Market Perform